Burrell Terry-Ann — SEC Form 4 filings
SEC reporting owner CIK 1786484. 7 Form 4 filings on record with FilingPulse; latest filed 2024-07-03.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-02 to 2024-07-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,446 shares, $174,926 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 5,446 shares @ $32.12 ($174,926) in Beam Therapeutics Inc., filed 2024-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | Chief Financial Officer | 4 | — | 1 leg · 5,446 sh · $174,926 | 4 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | 3 | — | — | 4 |
Form 4 filings — Burrell Terry-Ann
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,843 @ $0 | EDGAR |
| 2024-06-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,467 @ $0 | EDGAR |
| 2024-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 5,446 @ $32.12 | EDGAR |
| 2024-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 27,500 @ $0 | EDGAR |
| 2024-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 55,000 (derivative) @ $24.40 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786484 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →